Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 28 clinical trials
Compression Ultrasonography in Non-high Probability of Deep Vein Thrombosis (EPREVUP)

Compression ultrasound is commonly used in emergency department. Accuracy to rule out deep vein thrombosis is excellent but lower then Ddimer assessment which is actually gold standard. With progress in formation of emergency physicians (EP), quality of material used, the investigators hypothesize that compression ultrasound can rule out deep vein …

  • 0 views
  • 12 May, 2022
  • 1 location
Compression Hosiery to Avoid Post-Thrombotic Syndrome

Patients with a deep vein thrombosis (DVT) may develop long-term symptoms, e.g. lifelong leg pain, skin changes and occasionally ulceration, known as post-thrombotic syndrome (PTS). This affects about half of people with a history of DVT. This randomised study aims to show whether the regular use of a compression stocking …

deep vein thrombosis
clot
deep venous thrombosis of lower extremity
blood clot
dvts
  • 0 views
  • 16 Sep, 2021
  • 12 locations
A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay (EMBOL1)

In patients with symptoms of Venous Thromboembolism (VTE) (mainly deep vein thrombosis (DVT) or pulmonary embolism (PE)), the study will evaluate the agreement between the D-Dimer measurements from the LumiraDx POC D-Dimer assay and a reference method, as an aid in diagnosis, assessment and exclusion of DVT and PE.

diagnostic procedures
thrombosis
clot
thromboembolism
venous thromboembolism
  • 7 views
  • 16 Jun, 2022
  • 5 locations
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)

Design: U.S.-based, single-center, randomized placebo-controlled trial. Brief Treatment Description: Low-intensity apixaban (2.5mg twice daily) for extended-duration secondary prevention of VTE after initial treatment for provoked VTE. Purpose: To establish the safety and efficacy of low-intensity apixaban versus placebo for extended prevention of recurrence after provoked VTE in patients with at …

stroke
heart failure
venous thromboembolism
asthma
chronic lung disease
  • 0 views
  • 29 Jul, 2022
  • 1 location
Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events

The study will evaluate the effectiveness of a novel, real-time risk prediction model for identifying pediatric patients at risk for developing in-hospital blood clots (or venous thromboembolism [VTE]) based on data easily extracted from the electronic medical record. The study will assess whether using the risk percentages for developing VTE …

venous thromboembolism
blood clot
clot
thromboembolism
  • 0 views
  • 06 Mar, 2022
  • 1 location
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

The risk of developing a blood clot occurs in up to 60% of all critical care patients. Many times enoxaparin (or Lovenox) is given to patients who are at a higher risk of developing clots in their legs or lungs. There are two standard doses of enoxaparin that are recommended …

lovenox
clot
enoxaparin
blood clot
critical illness
  • 31 views
  • 02 May, 2022
  • 1 location
Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis

The goal of this study is to determine the safety and tolerability or efficacy of adjunctive treatments (including rosuvastatin 20 mg daily) in combination with standard anticoagulation therapy (Factor Xa inhibitors) in patients with lower extremity deep vein thrombosis (DVT). The efficacy of adjunctive treatments to prevent the development of …

  • 0 views
  • 22 Oct, 2021
  • 1 location
Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs (ULTREC)

The purpose is to assess the safety of a management strategy based on colour doppler ultrasound (CDUS) and D-Dimer test results for the diagnosis exclusion of recurrent deep vein thrombosis (DVT) of the lower limbs. DVT recurrence requires using anticoagulant treatment to prevent thrombosis progression. Given an increased bleeding risk …

clot
venous thrombosis
doppler ultrasound
thromboembolism
embolism
  • 37 views
  • 26 Mar, 2022
  • 33 locations
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome (TILE)

The TILE pilot study will be a multicenter, open-label, assessor-blinded RCT (randomized control trial) comparing extended LMWH (Low Molecular Weight Heparin) vs. DOAC (Direct Oral Anticoagulants) to PTS (prevent post thrombotic syndrome) in patients with DVT (Deep Vein Thrombosis).

rivaroxaban
clot
post thrombotic syndrome
tinzaparin
anticoagulants
  • 0 views
  • 10 May, 2022
  • 3 locations
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis

The objective of this study is to demonstrate the safety and efficacy of the Indigo Aspiration system for percutaneous mechanical thrombectomy in a population presenting with obstruction due to deep vein thrombosis (DVT) who are eligible for treatment.

blood clot
deep vein thrombosis
clot
deep venous thrombosis of lower extremity
thrombectomy
  • 0 views
  • 18 Jun, 2022
  • 1 location